IPCEI Med4CureIndustrial BiotechSynbio alliance strengthens EU corticosteroid supply chainThe French AI-synbio specialist Abolis Biotechnologies SAS has entered a strategic €140m alliance with API manufacturer EuroAPI SA under the IPCEI Med4Cure funding programme. Within the collaboration, … more ➔
adobe stock photos - Miha Creative Financing/PartneringVC investments rise nearly 71% in Q3 2025VC investments in biotech rose 70.9% in Q3 2025 to US$3.1bn, driven by Series D growth, M&A activity, and Fed interest rate cuts, reports Global Data. J.P. Morgan reports same trends but different f … more ➔
Pleiotrope - https://commons.wikimedia.org/w/index.php?curid=15999847Financing/PartneringElectra Therapeutics raises US$183m in Series C financingCalifornia-based biotech Electra Therapeutics Inc has secured US$183m in Series C financing. The investment comes from a consortium of four European investors and Mubadala Capital. Contrary to some … more ➔
Ipsen SAM&AIpsen acquires ImCheck in US$1bn dealPharma giant Ipsen will pay US$1bn to acquire French immuno-oncology firm ImCheck Therapeutics SAS. The deal includes US$350m upfront and up to US$650m in milestone payments. ImCheck focuses on butyrophilins, … more ➔
BIOCOM InterrelationsESMO 2025Tubulis presents first clinical data on ADC TUB-040Following its US$361 m Series C financing, Tubulis AG presented first Phase I/IIa data on its lead ADC, TUB-040, at ESMO 2025 in Berlin. The study focuseds on patients with platinum-resistant ovarian … more ➔
H Lundbeck A/SNeurology partnershipLundbeck inks licence option deal with Contera PharmaDanish companies H. Lundbeck A/S (Lundbeck) and Contera Pharma A/S have inked a strategic research collaboration aiming at accelerating the development of oligonucleotide-based treatments for medically … more ➔
© Merck KGaAUS Pharma PricesMerck KGaA reduces US prices for IVF drugs by 84%The Merck subsidiary EMD Serono has agreed to price reductions of up to 84% for its in vitro fertilisation products in the United States. To avoid paying pharmaceutical tariffs, the company will distribute … more ➔
Adcytherix SASFinancingADC specialist Adcytherix SAS raises €105m in Series A roundFrench ADC start-up Adcytherix SAS has added €105m Series A funding to a €30m seed financing round closed last year. With the money, the company will start a Phase I study with its lead ADCX-020 … more ➔
Tubulis GmbHADCTubulis secures €308m in record-breaking Series C financing Munich-Martinsried-based biotech Tubulis has closed a €308 million (USD 361 million) Series C financing round – the largest of its kind for a still existing European biotechnology company at the … more ➔
BioMed NVMainz BioMed NVBlood test detects pancreatic cancer earlyMainz Biomed NV may have taken a major step in early pancreatic cancer detection. The company reports that its multivariate RNA liquid biopsy test, licensed from Liquid Biosciences Inc. in March, achieved … more ➔
IPCEI Med4Cure
adobe stock photos - Miha Creative 
Pleiotrope - https://commons.wikimedia.org/w/index.php?curid=15999847
Ipsen SA
BIOCOM Interrelations
H Lundbeck A/S
© Merck KGaA
Adcytherix SAS
Tubulis GmbH
BioMed NV